SEC Filing Details
Document Details
Form
Filing Date
Jan 21, 2026
Document Date
Jan 21, 2026
Form Description
Registration of up to an additional 20% of securities for any offering registered on a S-3
Filing Group
Registration Statements
Company
Corvus Pharmaceuticals
Issuer
Corvus Pharmaceuticals, Inc.
